trending Market Intelligence /marketintelligence/en/news-insights/trending/_8NdmaRxSYRYkXybFucruw2 content esgSubNav
In This List

Transgenomic, Precipio merger secures stockholder approval

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Transgenomic, Precipio merger secures stockholder approval

Transgenomic Inc. received stockholder approval for its proposed merger with Precipio Diagnostics LLC.

Precipio Diagnostics stockholders also approved the deal.

The closing of the merger is still pending the combined company's $7 million private placement of preferred convertible securities and the conversion of all outstanding secured debt into preferred convertible securities.

The combined company will be renamed Precipio Inc. and be relisted on Nasdaq under the PRPO ticker symbol.